GoodRx Holdings, Inc. (NASDAQ: GDRX) reported Q1 EPS of $0.08, $0.01 better than the analyst estimate of $0.07. Revenue for the quarter came in at $197.9 million versus the consensus estimate of $196.09 million.

GUIDANCE:

GoodRx Holdings, Inc. sees Q2 2024 revenue of $200 million, versus the consensus of $199.6 million.

GoodRx Holdings, Inc. sees FY2024 revenue of $800-810 million, versus the consensus of $801 million.

For earnings history and earnings-related data on GoodRx Holdings, Inc. (GDRX) click here.